Title Information
Title
Modeling Development and Disease In Human Engineered Cardiac Tissue
Name: Personal
Name Part
Rupert, Cassady Elise
Role
Role Term: Text
creator
Name: Personal
Name Part
Coulombe, Kareen
Role
Role Term: Text
Advisor
Name: Personal
Name Part
Black, Lauren
Role
Role Term: Text
Reader
Name: Personal
Name Part
Colvin, Vicki
Role
Role Term: Text
Reader
Name: Personal
Name Part
Hurt, Robert
Role
Role Term: Text
Reader
Name: Personal
Name Part
Mathiowitz, Edith
Role
Role Term: Text
Reader
Name: Personal
Name Part
Mende, Ulrike
Role
Role Term: Text
Reader
Name: Corporate
Name Part
Brown University. Biology and Medicine: Biomedical Engineering
Role
Role Term: Text
sponsor
Origin Information
Copyright Date
2019
Physical Description
Extent
xii, 184 p.
digitalOrigin
born digital
Note: thesis
Thesis (Ph. D.)--Brown University, 2019
Genre (aat)
theses
Abstract
Cardiovascular engineering using human pluripotent stem cell (hPSC)-derived cardiomyocytes holds incredible potential for disease modeling, therapeutic development and testing, and cardiac regeneration. The heterogeneity and plasticity of hPSCs and hPSC-cardiomyocytes can be both assets and obstacles to the generation and advancement of new technologies, and a deeper understanding of how to manipulate these cells is needed. The research pursued in this dissertation explores novel means to engineer healthy and diseased states in hPSC-cardiomyocytes from the single-cell to tissue level. Studies were performed using a broad scale of metrics including cell and tissue structure, gene expression, bioenergetic phenotype, and electromechanical function in order to obtain a fuller picture of hPSC-cardiomyocyte response to mechanical, biochemical, and cellular stimuli. Important and novel findings show that (1) confocal microscopy imaging of single cells reveals hPSC-cardiomyocyte contractile lattice and cytosolic volume respond independently to hypertrophic stimulation; (2) developmental growth factors stimulate proliferation and metabolic maturation of hPSC-cardiomyocytes in engineered tissues; (3) adult human cardiac fibroblasts can be manipulated to produce physiological and pathophysiological phenotypes in engineered tissues; and (4) metabolic selection to purify hPSC-cardiomyocyte populations changes bioenergetic phenotype. Taken together, these results stress the importance of considering hPSC-cardiomyocyte immaturity and plasticity in engineered cardiac tissues, and that, because of these features, hPSC-cardiomyocytes provide unexpected avenues for engineering development and disease in the dish.
Subject
Topic
tissue engineering
Subject
Topic
induced pluripotent stem cells
Subject (fast) (authorityURI="http://id.worldcat.org/fast", valueURI="http://id.worldcat.org/fast/01765419")
Topic
Embryonic stem cells--Research
Subject (fast) (authorityURI="http://id.worldcat.org/fast", valueURI="http://id.worldcat.org/fast/00953714")
Topic
Heart cells
Language
Language Term (ISO639-2B)
English
Record Information
Record Content Source (marcorg)
RPB
Record Creation Date (encoding="iso8601")
20200720
Access Condition: rights statement (href="http://rightsstatements.org/vocab/InC/1.0/")
In Copyright
Access Condition: restriction on access
Collection is open for research.
Type of Resource (primo)
dissertations